Inventor · disambiguated record
John A. Gaudette
Also filed as: GAUDETTE JOHN · GAUDETTE JOHN A
18 granted patents·4 pending applications·95 citations·filing 2012–2025
93Inventor score
Top patents by PatentIndex Score
22 records- 0196US9393315B2Compounds for targeting drug delivery and enhancing siRNA activityNIITSU YOSHIRO·Filed 2012·Granted Jul 19, 2016·12 cites·17 claims
- 0296US9011903B2Cationic lipids for therapeutic agent delivery formulationsNIITSU YOSHIRO·Filed 2012·Granted Apr 21, 2015·26 cites·23 claims
- 0395US9963424B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2016·Granted May 8, 2018·8 cites·18 claims
- 0495US9242001B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2014·Granted Jan 26, 2016·14 cites·29 claims
- 0593US10196637B2Retinoid-lipid drug carrierNITTO DENKO CORP·Filed 2016·Granted Feb 5, 2019·7 cites·20 claims
- 0691US10100004B2Compounds for targeting drug delivery and enhancing siRNA activityNITTO DENKO CORP·Filed 2016·Granted Oct 16, 2018·4 cites·10 claims
- 0790US11084779B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2019·Granted Aug 10, 2021·2 cites·40 claims
- 0888US10167253B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2016·Granted Jan 1, 2019·6 cites·16 claims
- 0987US10000447B2Compounds for targeting drug delivery and enhancing siRNA activityNITTO DENKO CORP·Filed 2016·Granted Jun 19, 2018·2 cites·16 claims
- 1087US9308267B2Lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2013·Granted Apr 12, 2016·8 cites·21 claims
- 1186US11384051B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2018·Granted Jul 12, 2022·2 cites·14 claims
- 1282US11413243B2Fusogenic compounds for delivery of biologically active moleculesNITTO DENKO CORP·Filed 2018·Granted Aug 16, 2022·1 cites·23 claims
- 1382US10441659B2Lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2015·Granted Oct 15, 2019·3 cites·22 claims
- 1479US12319643B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2022·Granted Jun 3, 2025·0 cites·12 claims
- 1577US2025250226A1Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2025·Application pending·0 cites
- 1676US12440445B2Fusogenic compounds for delivery of biologically active moleculesNITTO DENKO CORP·Filed 2022·Granted Oct 14, 2025·0 cites·11 claims
- 1772US10669229B2Compounds for targeting drug delivery and enhancing siRNA activityNITTO DENKO CORP·Filed 2018·Granted Jun 2, 2020·0 cites·21 claims
- 1871US10532975B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2018·Granted Jan 14, 2020·0 cites·35 claims
- 1969US11103583B2Lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2019·Granted Aug 31, 2021·0 cites·17 claims
- 2050US2013210744A1Targeting agent for cancer cell or cancer-associated fibroblastNITTO DENKO CORP·Filed 2013·Application pending·0 cites
- 2150US2013171240A1Drug carrier and drug carrier kit for inhibiting fibrosisNITTO DENKO CORP·Filed 2013·Application pending·0 cites
- 2247US2016015656A2Composition for regenerating normal tissue from fibrotic tissueNITTO DENKO CORP·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →